Indium (111In) biciromab

From WikiMD's Wellness Encyclopedia


Indium (111In) biciromab
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category N/A
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status Withdrawn
CAS Number 138783-13-8
PubChem
DrugBank
ChemSpider none
KEGG D03111

Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,[2] but was withdrawn during clinical trials.[3]

References[edit | edit source]

  1. King, David J., Recombinant antibodies for the diagnosis and therapy of human disease, Current Opinion in Drug Discovery & Development, 1999, Vol. 2(Issue: 2),
  2. Answers.com: Centocor Ortho Biotech Products, L.P.
  3. DiagnosticImaging.com: Centocor withdraws imaging agent applications



Inmunoglobulina.png
   This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!
Medicine-stub.png
This article is a stub related to medicine. You can help WikiMD by expanding it!
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD